Article Details
Retrieved on: 2022-03-01 15:39:14
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca subsidiary Alexion has reportedly been granted an exclusive worldwide licence to develop, manufacture and commercialise NI006.
Article found on: ukinvestormagazine.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here